Clinical Trial Update: A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

This entry describes a Phase 1/2 clinical trial evaluating TS-1 in combination with irinotecan and cisplatin for advanced non-small cell lung cancer, sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Platinol (cisplatin)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN